Pre-clinical trials from a top preclinical Contract Research Organization in Kiev, Ukraine.
Our organization is an independent CRO operating out of the USA that conducts pre-clinical medicine testing in top-notch, GLP-certified testing sites in Eastern Europe. Our testing facilities are overseen by the UNAMS and Ministry of Health and provide services for commercial development of new medicine discoveries as part of their core purpose. Our business was founded to provide the high quality, lower cost services of these laboratories to start-up bio-technology companies in the United States and EU, thereby offering a smart option for advancing development programs quickly and at much lower cost than other commercial Contract Research Organizations. We provide a broad range of pre-clinical CRO including drug safety, acute and chronic toxicity, pharma screening, bio-availability , bio-equivalence , and complete in vitro and in vivo screening for anti-cancer activity.
Our preclinical Contract Research Organization is able to price preclinical testing far below other Contract Research Organizations because we have a very low overhead in the United States and conduct all trials in Kiev, UA where labor and facility costs are much lower. Our team in the USA consists only of the organization principals who deal directly with customers; we don’t have any promotion costs other than our site, and no central offices, supporting staff or other overhead to inflate costs. We have much lower research conduct prices in Ukraine due to much lower labor rates and are happy to offer our most attractive rates for longer and more intricate pre-clinical tests where labor is the most significant part of the overall cost. Since we use the same stable international providers for animal models, reagents and lab materials as other CROs, we have no cost advantage on these items and so less overall cost savings for very short-term pre-clinical tests. But, regardless of your study protocol and length, our goal is to provide our clients the best possible value for their money.